Odaily Planet Daily reports: Citrini analyst Jukan posted on X that Citibank has downgraded Micron, expecting the price increases for DRAM and NAND over the next four quarters to gradually slow, with prices projected to peak in the second fiscal quarter of next year, corresponding to May. Citibank revised its quarter-over-quarter DRAM price increase forecasts for August, November, February, and May from 23%, 10%, 2%, and 0% to 23%, 9%, 2%, and 0%, respectively, and now anticipates a 3% decline in prices in the second half of 2027 compared to the first half. NAND price increase forecasts were adjusted from 29%, 9%, 1%, and 0% to 29%, 7%, 0%, and -1%, with the second half of 2027 price outlook revised to a 5% decline compared to the first half. Citibank noted that capacity expansions by CXMT and YMTC will drive down DRAM and NAND prices. U.S.-listed memory chip stocks plunged sharply.
Citi Downgrades Micron, Forecasts Memory Prices to Peak in Q2 2027
KuCoinFlashShare
Summary
Citi downgraded Micron, forecasting DRAM and NAND prices to peak in Q2 2027. The bank revised its quarterly DRAM price growth projections from 23%, 10%, 2%, and 0% to 23%, 9%, 2%, and 0%, with a 3% decline expected in H2 2027. NAND forecasts were adjusted to 29%, 7%, 0%, and -1%, with a 5% drop anticipated in the second half. Citi cited increased output from ChangXin and Yangtze Memory as key factors. U.S. memory chip stocks plunged sharply. Altcoins to watch may react to shifts in the Fear & Greed Index amid market uncertainty.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.